alexa Alun McCarthy | Adorial Ltd
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Alun McCarthy

Alun McCarthy Alun McCarthy
Founder & CEO at Adorial
Wycombe Marsh,
Buckinghamshire, United Kingdom

Alun McCarthy is Founder & CEO at Adorial, Cytopathfinder, Wycombe Marsh in United Kingdom. Adorial Ltd is a virtual drug discovery company using a proprietary in silico genomics platform to identify novel drug targets.

Research Interest

Drug Discovery, Drug Development, Pharmacogenomics, Pharmacogenetics, Biomarkers, Biomarker Discovery, CNS disorders, Cardiovascular Disease, Strategic Leadership, Technical Leadership, Clinical Research, Clinical Trials, Pharmaceutical Industrym, Life Sciences, Clinical Development, Biotechnology, Genomics, Medical Diagnostics

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version